Work Productivity Improvements in Adalimumab-treated Patients with Moderate to Severe Ileocolonic Crohn's Disease: The EXTEND Trial

被引：1
|
作者：
Binion, David [1 ]
Rutgeerts, Paul [2 ]
van Assche, Gert [2 ]
Chen, Naijun [3 ]
Chao, Jingdong [3 ]
Mulani, Parvez [3 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium
[3] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2009年 / 104卷
关键词：
D O I：
10.14309/00000434-200910003-01238
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1238
引用
收藏
页码：S462 / S462
页数：1
相关论文
共 50 条
  • [31] Predicting PASI90 response among adalimumab-treated patients with moderate to severe psoriasis
    Ryan, Caitriona
    Sundaram, Murali
    Yang, Min
    Goyal, Ravi
    Zhou, Zhou
    Signorovitch, James
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB263 - AB263
  • [32] Improvement in short inflammatory bowel disease questionnaire scores in adalimumab-treated Crohn's disease patients who failed infliximab (CHOICE trial)
    Lichtiger, Simon
    Present, Daniel H.
    Wu, Eric
    Beaulieu, Nicolas
    Kent, Jeffrey D.
    Lomax, Kathleen G.
    Chao, Jingdong
    Mulani, Parvez
    GASTROENTEROLOGY, 2008, 134 (04) : A474 - A475
  • [33] Relationship Between Extraintestinal Manifestations of Crohn's Disease and Patient-Reported and Disease Activity Outcomes in Adalimumab-Treated Patients in the Care Trial
    Reinisch, Walter
    Lofberg, Robert
    Louis, Edouard
    Yu, Andrew P.
    McHale, Joshua
    Beaulieu, Nicolas
    Chao, Jingdong
    Mulani, Parvez
    GASTROENTEROLOGY, 2009, 136 (05) : A204 - A205
  • [34] Steroid-free remission in adalimumab-treated paediatric patients with moderately to severely active Crohn's disease in the IMAgINE 1 trial
    Griffiths, A.
    Crandall, W.
    Colletti, R.
    Ruemmele, F.
    Faubion, W. A.
    Hyams, J.
    Lazar, A.
    Li, Y.
    Eichner, S.
    Thakkar, R. B.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S12 - S12
  • [35] Steroid-Free Remission in Adalimumab-Treated Pediatric Patients With Moderately to Severely Active Crohn's Disease in the IMAgINE 1 Trial
    Griffiths, Anne M.
    Crandall, Wallace
    Colletti, Richard B.
    Ruemmele, Frank
    Faubion, William A.
    Hyams, Jeffrey S.
    Lazar, Andreas
    Li, Yao
    Eichner, Samantha
    Thakkar, Roopal
    GASTROENTEROLOGY, 2014, 146 (05) : S213 - S213
  • [36] Achievement of early deep remission predicts better long-term outcomes for adalimumab-treated patients with Crohn's disease: Data from EXTEND.
    Sandborn, W.
    Colombel, J.
    Rutgeerts, P.
    Yang, M.
    Lomax, K.
    Pollack, P.
    Thakkar, R.
    Camez, A.
    Chen, N.
    Chao, J.
    Mulani, P.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S60 - S60
  • [37] Identification of Subgroups of Adalimumab-Treated Patients With Crohn's Disease Who Experience High Rates of Deep Remission
    Sandborn, William J.
    Colombel, Jean-Frederic
    Louis, Edouard
    Panaccione, Remo
    Yang, Mei
    Chao, Jingdong
    Mulani, Parvez
    GASTROENTEROLOGY, 2011, 140 (05) : S214 - S214
  • [38] Resolution of flare or nonresponse in patients with Crohn's disease achieved in most adalimumab-treated patients without a dosage increase
    Plevy, Scott
    Schreiber, Stefan
    Colombel, Jean Fred
    Pollack, Paul
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S383 - S384
  • [39] EFFICACY AND SAFETY OF ADALIMUMAB IN MODERATE COMPARED WITH SEVERE CROHN'S DISEASE: POOLED DATA FROM THE CHARM AND EXTEND TRIALS
    Colombel, J-F
    Sandborn, W. J.
    Castillo, M. M.
    Zhou, Q.
    Thakkar, R. B.
    GUT, 2012, 61 : A229 - A229
  • [40] Severe Fistulizing and Fibrostenosing Crohn's Disease Treated With Adalimumab
    Oglat, Ayah
    Koduru, Pramoda
    Patel, Pragnesh
    Abraham, Bincy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1087 - S1088
12345